迪巧品牌怎么样 申请店铺

我要投票 迪巧在钙片行业中的票数:324 更新时间:2025-04-03
迪巧是哪个国家的品牌?「迪巧」是安士制药(中山)有限公司旗下著名品牌。该品牌发源于广东,由创始人徐清波在2003-09-19期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力迪巧品牌出海!通过在本页面挂载迪巧品牌的产品链接和联系邮箱,可以提高迪巧产品曝光!跨境电商爆单神器,目前只要100元/年哦~

迪巧怎么样

迪巧是由美国安士制药有限公司按F.LA标准在美国生产的品牌产品。精选全球50多个优质钙源,是经过国际先进工艺提纯的精制碳酸钙,安全性极高。迪巧科学添加了维生素D3,具有安全、足量、好吸收的三大优点。同时,迪巧针对中国不同年龄段人群对钙制剂需求的特点,特别设计了个性配方和口味。有专为0-3岁宝宝设计的迪巧小儿碳酸钙D3颗粒,专为3岁以上儿童设计的迪巧儿童维D钙咀嚼片,专为成人计的迪巧维D钙咀嚼片以及专为更年期女性设计的迪巧秀源女性片。

迪巧是中国优生科学协会唯一推荐钙补充剂,经中国优生科学协会审核论证,连续10年被作为唯一推荐补钙制剂。2010年中国家庭药箱调查显示,迪巧名列中国居民信赖的家庭常备药排名前三。该调查由中国非处方药物协会、中国医药质量管理协会、中国药学会发布。迪巧荣获中国健康年度总评榜“最受欢迎补钙用药”。2010年39健康网开展了健康年度总评榜,由网民自行投票选出最欢迎的药品品牌,迪巧荣获最受欢迎补钙用药之一。迪巧连续3年荣获“健康中国2010中国药品品牌榜”上榜品牌称号。迪巧连续3年荣获“2008-2009年度店员推荐率最高品牌”。2009年10月29日至31日,《中国药店》杂志社举办了第九届中国药店高峰论坛暨"2008-2009年度店员推荐率最高品牌"揭晓会议,来自全国连锁店、及卫生部、国家药监局的百余人到场。迪巧深受药店专业人员信赖,被大会评为“2008-2009年度店员推荐率最高品牌”。这已经是迪巧连续三年荣获此奖项。

安士制药(中山)有限公司位于广东省中山市火炬开发区国家健康基地,是由以美国安士集团有限公司,中山市健康科技产业基地发展有限公司和百洋集团有限公司为主的几家公司共同投资的一家集科研开发、生产和市场建设于一体的新型医药生产企业。

公司首期占地面积二万多平方米,拥有近一万四千平方米的现代化厂房,已建成两个固体制剂车间、冻干粉针车间、软胶囊车间和质检中心。全部生产车间都通过了国家和省食品药品监督管理局认证中心的GMP认证。固体制剂车间于2010年5月通过美国FDA现场验证。

安士以科研开发为先导,研究开发自产产品。同时引进国外先进生产技术及产品信息,已形成的迪巧系列补钙制剂为国内名列前茅的大品种。此外,安士一直致力于处方药出口美国为主攻目标,培育一支适应国际化生产要求的管理团队和员工队伍。

2007年3月,安士生物科技(中山)有限公司成立,专门从事保健品的软胶囊研发和生产,从而满足软胶囊制剂在国内外市场销售快速发展的需要。

安士制药(中山)有限公司的宗旨是进一步提高安士品牌的美誉度和信任度,极大地丰富安士与人类健康息息相关的品牌内涵。公司的目标是建立一个适应新剂型、新品种发展的药品生产基地,努力在制药市场上形成一个重要的、诚信可靠的企业,为人类的健康事业做出贡献。

Diqiao is a brand product manufactured in the United States by axis Pharmaceutical Co., Ltd. according to f.la standard. More than 50 high-quality calcium sources in the world are selected. They are refined calcium carbonate purified by international advanced technology, with high safety. Diqiao added vitamin D3 scientifically, which has three advantages of safety, sufficient quantity and good absorption. At the same time, Diqiao specially designed the individual formula and taste according to the characteristics of different age groups in China. There are Diqiao children's calcium carbonate D3 granules specially designed for 0-3 years old children, Diqiao children's vitamin D calcium chewable tablets specially designed for children over 3 years old, Diqiao vitamin D calcium chewable tablets specially designed for adults and Diqiao Xiuyuan women's tablets specially designed for menopausal women. Diqiao is the only calcium supplement recommended by China eugenics Association. It has been the only calcium supplement recommended by China eugenics Association for 10 consecutive years. According to the 2010 survey of family medicine kits in China, Diqiao ranked in the top three list of household medicines trusted by Chinese residents. The survey was released by China over the counter drug association, China Pharmaceutical Quality Management Association and China Pharmaceutical Association. Diqiao won the "most popular calcium supplement" in China's annual health review. In 2010, 39 health.com launched the annual health evaluation list, and the Internet users voted to select the most popular drug brand. Diqiao won one of the most popular calcium supplements. Diqiao has won the title of "healthy China 2010 Chinese drug brand list" for three consecutive years. Diqiao has been awarded "the highest brand recommended by shop assistants in 2008-2009" for three consecutive years. From October 29 to 31, 2009, China drugstore magazine Co., Ltd. held the 9th China drugstore Summit Forum and the unveiling meeting of "the highest recommended brand of staff in 2008-2009". More than 100 people from the national chain stores, the Ministry of health and the State Food and Drug Administration attended. Diqiao is deeply trusted by drugstore professionals and was rated as the "top brand with the highest recommended rate of salesmen in 2008-2009" by the conference. This is the third consecutive year that Diqiao has won this award. Anshi Pharmaceutical (Zhongshan) Co., Ltd. is located in the national health base of Torch Development Zone, Zhongshan City, Guangdong Province. It is a new pharmaceutical production enterprise, which is jointly invested by several companies mainly including Anshi Group Co., Ltd., Zhongshan Health Science and Technology Industrial Base Development Co., Ltd. and Baiyang Group Co., Ltd. The first phase of the company covers an area of more than 20000 square meters, with a modern plant of nearly 14000 square meters. Two solid preparation workshops, freeze-dried powder injection workshops, soft capsule workshops and quality inspection centers have been built. All production workshops have passed the GMP certification of national and provincial food and Drug Administration certification center. The solid preparation workshop passed the FDA field verification in May 2010. With scientific research and development as the guide, axis researches and develops its own products. At the same time, the introduction of foreign advanced production technology and product information, has formed Diqiao series of calcium supplements for the domestic top big varieties. In addition, axis has been committed to the export of prescription drugs to the United States as the main goal, and cultivate a management team and staff team to meet the requirements of international production. In March 2007, axis Biotechnology (Zhongshan) Co., Ltd. was established, specializing in the research, development and production of soft capsules for health products, so as to meet the needs of rapid development of soft capsule sales in domestic and foreign markets. The aim of axis Pharmaceutical (Zhongshan) Co., Ltd. is to further improve the reputation and trust of axis brand and greatly enrich the brand connotation of axis closely related to human health. The company's goal is to establish a pharmaceutical production base to adapt to the development of new dosage forms and new varieties, strive to form an important, honest and reliable enterprise in the pharmaceutical market, and make contributions to human health.

本文链接: https://brand.waitui.com/7cdc17c05.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

稀土永磁板块短线拉升,九菱科技涨超10%

36氪获悉,截至发稿,稀土永磁板块短线拉升,九菱科技涨超10%,英思特、正海磁材、金力永磁、银河磁体、西磁科技等跟涨。

48分钟前

毕马威:人形机器人去年融资规模超72亿元,近年年均复合增长率35.6%

毕马威发布报告称,人形机器人作为具身智能的代表形态之一,市场前景广阔。2024年全球人形机器人市场规模达到20.3亿美元,预计到2029年将达到132.5亿美元,年均复合增长率约45.5%。“投融资方面,中国具身智能的投融资市场正呈现热潮调整、恢复向好的趋势。2024年具身智能融资共182笔,金额为140.5亿元,出现复苏现象。”毕马威指出,“作为具身智能子赛道,人形机器人因丰富的应用场景与技术发展潜力,其融资表现逆势增长,融资规模从2020年的15.8亿元升至去年的72.3亿元,年均复合增长率为35.6%。”(澎湃)

48分钟前

3月份部分热点城市房地产市场活跃度大幅提升

据中国房地产业协会,得益于供给放量、房企营销力度增加,以及政策效应持续释放的多重因素推动下,3月份部分热点城市房地产市场活跃度大幅提升。回暖迹象明显。特别是一线城市及部分核心二线城市,新房和二手房成交量环比显著增长,迎来一波局部“小阳春”行情。克而瑞数据显示,2025年3月份30个监测城市新房成交规模为1230万平方米,环比增长79%,同比上升4%。春节后季节性需求释放、政策宽松及房企促销推动成交回升,一季度30城累计成交2810万平方米,同比上涨7%。(证券时报)

48分钟前

小鹏汽车在成都成立销售服务新公司,注册资本500万

36氪获悉,天眼查App显示,近日,成都悦鹏汽车销售服务有限公司成立,法定代表人为韩键,注册资本500万人民币,经营范围包括新能源汽车整车销售、新能源汽车电附件销售、机动车充电销售、电池零配件销售、汽车零配件批发、小微型客车租赁经营服务等,由成都小鹏汽车销售服务有限公司全资持股。

48分钟前

国家绿色发展基金入股宜宾高投产业发展公司

36氪获悉,天眼查App显示,近日,宜宾高投产业发展有限公司发生工商变更,新增国家绿色发展基金股份有限公司为股东,同时注册资本由10亿人民币增至约13.8亿人民币。该公司成立于2023年2月,法定代表人为何流,经营范围包括自有资金投资的资产管理服务、企业管理、融资咨询服务等,现由宜宾市高新投资集团有限公司及上述新增股东共同持股。

48分钟前

本页详细列出关于盖中盖的品牌信息,含品牌所属公司介绍,盖中盖所处行业的品牌地位及优势。
咨询